Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2020-12-11 | 2020-12-11 |
| Drug Identification Number | 02223767 | 02223767 |
| Brand name | NORPROLAC | NORPROLAC |
| Common or Proper name | Quinagolide Hydrochloride | Quinagolide Hydrochloride |
| Company Name | FERRING INC | FERRING INC |
| Ingredients | QUINAGOLIDE | QUINAGOLIDE |
| Strength(s) | 0.075MG | 0.075MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 30 tablets per carton | 30 tablets per carton |
| ATC code | G02CB | G02CB |
| ATC description | OTHER GYNECOLOGICALS | OTHER GYNECOLOGICALS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2020-12-02 | 2020-12-02 |
| Actual discontinuation date | 2020-12-09 | 2020-12-09 |
| Remaining supply date | 2020-12-02 | 2020-12-02 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | NORPROLAC 150 mcg tablets (DIN 02223767) and NORPROLAC starter pack containing 25 mcg (DIN 02223740) and 50 mcg (DIN 02223759) tablets are in stock and available. | NORPROLAC 150 mcg tablets (DIN 02223767) and NORPROLAC starter pack containing 25 mcg (DIN 02223740) and 50 mcg (DIN 02223759) tablets are in stock and available. |
| Health Canada comments |